Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
2,206 questions in 117 reviews · Common Mental Disorders
current versionsNo studies 387 · 17.5%Ungraded 111 · 5%Very low 635 · 28.8%Low 568 · 25.7%Moderate 449 · 20.4%High 56 · 2.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Change in hospital admission rates · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Attempted suicide · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cost‐effectiveness of interventions (the study reviewed suicide data from a bridge and surrounding areas over a 70‐year period, and estimated reductions in mortality due to the barrier over a 20‐year period) · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | 1 study · 1 participants | Low |
Intervention NR Suicide (Observation period: pre‐intervention 19.5 years; postintervention 6.5 years) · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | IRR 0.09 | 2 studies · 2 participants | Low |
Intervention NR Attempted suicide · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Study withdrawal · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in hospital admission rates · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cost‐effectiveness of interventions · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Study withdrawal · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in hospital admission rates · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cost‐effectiveness of interventions · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Suicide (Observation period ‐ pre‐intervention: 89 years; postintervention 78.5 years) · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | IRR 0.05 | 9 studies · 9 participants | Low |
Intervention NR Attempted suicide · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Study withdrawal · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in hospital admission rates · adults or children of all ethnicities Means restriction for the prevention of suicide by jumping (2020) · Cochrane | no estimate extracted | NR | No studies |
Antidepressants plus benzodiazepines vs antidepressants alone Depression severity: early phase (2 weeks, range 1–4 weeks) · people with major depression Antidepressants plus benzodiazepines for adults with major depression (2019) · Cochrane | no estimate extracted | 10 studies · 598 participants | Moderate |
Antidepressants plus benzodiazepines vs antidepressants alone Depression severity: acute phase (8 weeks, range 5–12 weeks) · people with major depression Antidepressants plus benzodiazepines for adults with major depression (2019) · Cochrane | no estimate extracted | 7 studies · 347 participants | Low |
Antidepressants plus benzodiazepines vs antidepressants alone Depression severity: continuous phase (> 12 weeks) · people with major depression Antidepressants plus benzodiazepines for adults with major depression (2019) · Cochrane | no estimate extracted | 1 study · 50 participants | Low |
Antidepressants plus benzodiazepines vs antidepressants alone Acceptability of treatment (dropout for any reason) · people with major depression Antidepressants plus benzodiazepines for adults with major depression (2019) · Cochrane | RR 0.76 [0.54, 1.07] | 10 studies · 731 participants | Moderate |
Antidepressants plus benzodiazepines vs antidepressants alone Anxiety severity: early phase (2 weeks, range 1–4 weeks) · people with major depression Antidepressants plus benzodiazepines for adults with major depression (2019) · Cochrane | no estimate extracted | 3 studies · 129 participants | Very low |
Antidepressants plus benzodiazepines vs antidepressants alone Adverse effects (dropouts) · people with major depression Antidepressants plus benzodiazepines for adults with major depression (2019) · Cochrane | RR 0.54 [0.32, 0.9] | 10 studies · 731 participants | Moderate |
Exercise therapy vs control FatigueMeasured at end of treatment (12‐26 weeks) · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 7 studies · 840 participants | Moderate |
Exercise therapy vs control Depression Measured at end of treatment; 12‐26 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 5 studies · 504 participants | Very low |
Exercise therapy vs control Depression Measured after 52‐70 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 4 studies · 654 participants | Very low |
Exercise therapy vs control Sleep Measured at end of treatment, 12‐26 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 2 studies · 323 participants | Low |
Exercise therapy vs control Sleep Measured after 52‐70 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 3 studies · 610 participants | Low |
Exercise therapy vs psychological treatment Fatigue Measured at end of treatment, 24 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 298 participants | Low |
Exercise therapy vs psychological treatment Fatigue Measured after 52 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 2 studies · 351 participants | Moderate |
Exercise therapy vs psychological treatment Participants with serious adverse reactions Measured after 52 weeks Measured according to European Union Clinical Trials Directive by recording the number of serious reactions · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | RR 0.67 [0.11, 3.96] | 1 study · 321 participants | Very low |
Exercise therapy vs psychological treatment Pain intensity End of treatment · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs psychological treatment Pain intensity Measured after 52 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 43 participants | Very low |
Exercise therapy vs psychological treatment Physical functioning Measured at end of treatment, 24 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 298 participants | Low |
Exercise therapy vs control FatigueMeasured after 52‐70 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 4 studies · 670 participants | Very low |
Exercise therapy vs psychological treatment Physical functioning Measured after 52 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 2 studies · 348 participants | Very low |
Exercise therapy vs psychological treatment Quality of Life (QoL) · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs psychological treatment Quality of Life (QoL) Measured after 52 weeks Measured on the Quality of Life Scale, 16‐112 points High score means better quality of life · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 44 participants | Very low |
Exercise therapy vs psychological treatment Depression · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs psychological treatment Depression Measured after 52 weeks HADS depression score (0‐21 points) or Beck Depression Inventory‐II (0‐63 points) Low score means fewer symptoms · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 2 studies · 331 participants | Moderate |
Exercise therapy vs psychological treatment Sleep · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs psychological treatment Sleep Measured after 52 weeks Jenkins Sleep Scale, 0‐20 points Low score means better sleep · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 287 participants | Low |
Exercise therapy vs adaptive pacing therapy Fatigue Measured at end of treatment, 24 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 305 participants | Low |
Exercise therapy vs adaptive pacing therapy Fatigue Measured at end of treatment, 52 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 307 participants | Low |
Exercise therapy vs adaptive pacing therapy Participants with serious adverse reactions Measured after 52 weeks Measured according to European Union Clinical Trials Directive by recording the number of serious reactions · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | RR 0.99 [0.14, 6.97] | 1 study · 319 participants | Very low |
Exercise therapy vs control Participants with serious adverse reactions Measured after 52 weeks Measured according to European Union Clinical Trials Directive by recording the number of serious reactions · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | RR 0.99 [0.14, 6.97] | 1 study · 319 participants | Very low |
Exercise therapy vs adaptive pacing therapy Pain End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs adaptive pacing therapy Physical functioning Measured at end of treatment, 24 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 305 participants | Low |
Exercise therapy vs adaptive pacing therapy Physical functioning Measured at end of treatment, 52 weeks · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 307 participants | Low |
Exercise therapy vs adaptive pacing therapy Quality of Life (QOL) End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs adaptive pacing therapy Depression Measured at end of treatment · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise therapy vs adaptive pacing therapy Depression Measured after 52 weeks HADS depression score, 0‐21 points Low score means fewer symptoms · men and women aged over 18 years with chronic fatigue syndrome Exercise therapy for chronic fatigue syndrome (2019) · Cochrane | no estimate extracted | 1 study · 293 participants | Low |